Mechanistic studies revealed that FTO inhibits OGDHL expression in ccRCC through RNA m6A methylation, which downregulates FASN, leading to lipid accumulation and ERK pathway activation. The gene discussed is FASN; the disease is nonpapillary renal cell carcinoma.